Stocks · Korea 217730 KOSDAQ

Kangstem Biotech

2,215원 -3.28% Market cap 2,083억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR3.03x
EPS0 KRW
BPS730 KRW
ROE-16.27%
DPS0 KRW

Returns and 52-week range

1W+6.49%
1M+1.61%
3M-14.81%
6M-37.61%
1Y+38.44%
YTD+2.55%
52W high4,690원
52W low1,372원
From 52W high-52.77%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2021124억-227억-218억-183.3%
2022163억-206억-202억-126.1%
2023127억-228억-232억-179.3%
202536억-177억-105억-494.6%
Quarterly
2023 3Q30억-57억-57억-189.8%
2023 4Q34억-50억-55억-146.3%
2024 1Q29억-43억-42억-147.7%
2024 2Q23억-45억46억-197.7%
2024 3Q8억-40억-40억-508.5%
2026 1Q8억-46억-46억-567.6%

Company

CEO나종천
Founded2010-10-29
Fiscal year end12
Address: 서울특별시 강남구 테헤란로 522 홍우빌딩 9층

Peers in the same sector

CompanyMarket capP/EP/B1M
바이넥스2,128억—1.11-2.84%
녹십자웰빙1,958억19.331.72+1.40%
바디텍메드2,175억9.100.92+1.22%
영진약품1,955억—2.14-3.87%
듀켐바이오2,222억34.064.49+26.01%
코오롱생명과학1,930억7.370.33+1.17%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.